US regulatory status: approved.
pharma · Fatty Liver · Inflammatory Disease · GLMD
Galmed Pharmaceuticals
Galmed Pharmaceuticals drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- 16 Ze’ev Tiomkin Street, Tel Aviv, 6578317, IL, USA
- Founded
- 2000
- Employees
- 10
- Programs
- 13
- Drugs
- 5
- Patents
- 11
Galmed Pharmaceuticals pipeline
Portfolio lens on 5 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Galmed Pharmaceuticals drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Galmed Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Galmed Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Galmed Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Galmed Pharmaceuticals in public FDA and regional records.